{
    "title": "109_s2255",
    "content": "The Act titled \"Medicare Drug Formulary Protection Act\" allows for the removal of covered Part D drugs from the prescription drug plan formulary. The Medicare Drug Formulary Protection Act prohibits the removal or restriction of covered Part D drugs from the prescription drug plan formulary starting in 2006. The Medicare Drug Formulary Protection Act prohibits limitations on drug coverage, such as preferred status or quantity restrictions, except at the beginning of each plan year or for new therapeutic uses. Newly enrolled individuals cannot have covered drugs removed from their plan. The Medicare Drug Formulary Protection Act prevents PDP sponsors from removing covered drugs or imposing restrictions on drug coverage for newly enrolled individuals, except for new therapeutic uses or newly covered drugs, until the end of the plan year. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered drugs or imposing restrictions on drug coverage for new enrollees until the end of the plan year, with exceptions for new therapeutic uses and newly covered drugs. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered drugs or imposing restrictions on drug coverage for new enrollees until the end of the plan year, with exceptions for new therapeutic uses and newly covered drugs. The Act also outlines specific circumstances under which a drug can be removed or restricted, such as if it goes off-patent, receives a clinical warning, or is determined to be ineffective. The Medicare Drug Formulary Protection Act prohibits PDP sponsors from removing covered drugs or imposing restrictions on drug coverage for new enrollees until the end of the plan year. Exceptions include new therapeutic uses and newly covered drugs. The Act also specifies circumstances for drug removal or restriction, such as off-patent status, clinical warnings, or ineffectiveness. PDP sponsors must provide notice of any changes to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists. Additionally, PDP sponsors must furnish each enrollee with annual notice of changes in formulary and coverage restrictions. The Medicare Drug Formulary Protection Act requires PDP sponsors to provide annual notice of any changes in formulary or coverage restrictions to enrollees during the coordinated election period. The amendment specifies that changes must be communicated to enrollees before the start of the plan year."
}